Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BEND5 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | MAPK8IP2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | ADAM22 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | TTLL7 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | WHSC1L1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | RNF144A | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | FBXL4 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | NCAM1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | DUSP8 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | GP1BB | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |